| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.35B | 17.84B | 15.59B | 19.29B | 22.54B | 22.17B |
| Gross Profit | 1.33B | 1.39B | 1.98B | 2.28B | 3.42B | 2.92B |
| EBITDA | 1.93B | 1.97B | 2.06B | 2.34B | 3.04B | 2.48B |
| Net Income | 268.62M | 302.08M | 262.80M | 318.23M | 1.38B | 502.29M |
Balance Sheet | ||||||
| Total Assets | 25.19B | 24.75B | 24.51B | 26.49B | 29.73B | 26.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.23B | 1.07B | 802.29M | 1.70B | 1.65B | 1.40B |
| Total Debt | 6.93B | 6.70B | 6.68B | 7.41B | 6.79B | 6.30B |
| Total Liabilities | 15.64B | 15.40B | 14.68B | 16.15B | 18.07B | 16.06B |
| Stockholders Equity | 9.44B | 9.22B | 9.60B | 9.99B | 11.28B | 9.37B |
Cash Flow | ||||||
| Free Cash Flow | 6.62B | 6.83B | 4.77B | 3.68B | 5.30B | 1.23B |
| Operating Cash Flow | 7.03B | 7.40B | 5.28B | 4.57B | 5.83B | 2.29B |
| Investing Cash Flow | -1.62B | -1.81B | -825.53M | -1.70B | -587.08M | -1.08B |
| Financing Cash Flow | -5.40B | -5.38B | -4.50B | -2.80B | -4.31B | -506.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$3.38B | 11.70 | 8.69% | 3.25% | 19.25% | -10.14% | |
69 Neutral | HK$604.67M | 4.24 | 3.60% | 3.73% | 2.10% | ― | |
67 Neutral | HK$2.87B | 1.00 | 93.70% | 46.02% | 12.26% | 2497.49% | |
66 Neutral | HK$2.67B | 20.59 | 6.63% | 1.01% | 46.98% | 130.04% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | HK$2.85B | 12.09 | 2.88% | 9.26% | 2.59% | 0.23% | |
47 Neutral | HK$383.46M | 59.54 | 0.41% | 0.63% | 5.72% | -57.39% |